← SynDRA
LY2979165
SynDRA canonical compound SYN0039848 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | GRM2 |
|---|
| Mechanism of action | glutamate receptor agonist |
|---|
All known targets
Mechanisms of action (all sources)
- GRM2 AGONIST
- Metabotropic glutamate receptor 2 agonist
- glutamate receptor agonist
- GRM2 MODULATOR
Cross-references
Synonyms
- HY-13239
- LY-2979165
- Bipolar disorder therapy, Eli Lilly
- UNII-739DM5514X
- RefChem:154550
- orb1738482
- SCHEMBL1985392
- SCHEMBL6861452
- BRD-K68220839-413-01-0
- BRD-K68220839-413-02-8
- EX-A2093
- LY-2979165 ammonium monohydrate
- AKOS040741988
- orb1308097
- T15812
- MFCD25541740
- AS-56455
- CS-0457
- RefChem:201526
- C13H22N6O6S
- LY2979165 Ammonium salt
- LY2979165?
- (1R,2S,4R,5R,6R)-2-[[(2S)-2-Amino-1-oxopropyl]amino]-4-(1H-1,2,4-triazol-5-ylthio)-bicyclo[3.1.0]hexane-2,6-dicarboxylic acid ammonium salt hydrate (1:1:1)
- UNII-04MW5TZ18S
- GLXC-90378
- AKOS037748829
- mGlu2 agonist
- AC-35929
Look up LY2979165 in the interactive SynDRA portal →